Hospira
Parent Pfizer | | |
Website | www |
---|
Hospira was an American global
Worldwide sales in 2014 were approximately $4.5 billion.[4] Current results are now part of Pfizer's consolidated statements.
History
In January 2004, Abbott announced it was spinning off its hospital products division.[5]
Hospira's name was picked by employee vote. The name is derived from the words "hospital," "spirit," "inspire," and spero, a Latin word meaning "hope."[3][dead link] Hospira became an independent company on May 3, 2004, with 14,000 employees, 14 manufacturing sites and an estimated $2.5 billion in annual sales.[6]
In 2007, Hospira purchased Mayne Pharma Ltd., an Australian-based specialty injectable pharmaceuticals company, for $2.1 billion.[7]
In 2009, Hospira acquired the biotechnology business from Pliva-Croatia, the generic injectable pharmaceuticals business of
In 2011, Hospira's board chose Mike Ball, formerly president of Allergan, as Hospira's new CEO. Ball became CEO in March 2011.[11] Hospira named John Staley its non-executive chairman with the retirement of former executive chairman Christopher Begley in January 2012. Begley had announced his retirement as Hospira's chief executive in August 2010, but had remained as executive chairman.[12]
In 2015, Pfizer signed an agreement to acquire Hospira.[13] The roughly $17 billion acquisition was completed in September, 2015.[14] A year later Pfizer sold the medical devices portion of Hospira to ICU Medical for roughly $900 million in cash, stock, and other consideration.[15][16][17]
In 2020 through 2022, Pfizer used Hospira, Inc. as a trade name in reference to the subsidiary's involvement in as a supplier of 0.9%
Sodium thiopental production
In January 2011, the company announced that it would stop producing sodium thiopental.[22] Hospira had recently moved production of the drug from a plant in North Carolina to a plant in Liscate, Italy.[22] However, the Italian government would only allow Hospira to manufacture it if they could guarantee it wouldn't be used in capital punishment.[23] The Italian constitution bans the use of capital punishment.[24] Company officials determined there was no way it could prevent sodium thiopental from being used in executions, and did not want to expose their employees to liability.[25][24][26]
Legislation and litigation
In August 2009, Hospira introduced a
In 2010, the
Competitors
Hospira's competitors in specialty injectable pharmaceuticals include Fresenius AG, Baxter International Inc., Bedford Laboratories, Mylan, Sandoz, Teva Pharmaceuticals as well as divisions of several multinational pharmaceutical companies. Its competitors in medication management systems include Baxter, B. Braun Melsungen AG, CareFusion and Fresenius Medical Care AG.[29]
Infusion pump system firmware vulnerability disclosures
In 2014-2015 two
References
- ^ "Hospira - Investor Relations - Shareholder FAQ". Archived from the original on 28 December 2015.
- ^ "US-based Hospira to buy Orchid Chemicals' injectables biz for $400 mn". The Economic Times. 16 December 2009.
- ^ a b "About Hospira".
- ^ "HSP Key Statistics". Yahoo.com.
- ^ Higginbotham, Stacey (25 January 2004). "Abbott Labs to spin off unit". Austin Business Journal.
- ISSN 0099-9660. Retrieved 2020-04-23.
- ^ "Hospira close to purchase of Mayne". Chicago Tribune. 19 January 2007. Retrieved 2020-04-23.
- ^ "US-based Hospira to Buy Orchid Chemical's Injectables Biz For $400 Mn". The Economic Times. 16 December 2009.
- ^ "Hospira Acquires Theradoc, Enhances Medication Safety and Infection Management Offerings". Infection Control Today. 2 December 2009.
- ^ "Hospira To Close $145M Javelin Deal This Week". BusinessWeek. 29 June 2010. Archived from the original on 26 October 2012.
- ^ "Hospira Names Allergan's Michael Ball as CEO". Daily Herald. 8 March 2011.
- ^ "Hospira names John Staley non-executive chairman - MarketWatch". Archived from the original on 2012-07-07. Retrieved 2012-04-11.
- ^ "Pfizer to buy Hospira to boost biosimilar pipeline". CNBC. 5 February 2015.
- ^ "Pfizer completes $17-billion Hospira acquisition". The Pharma Letter. 4 September 2015. Retrieved 28 April 2017.
- TheStreet.com. Retrieved 28 April 2017.
- ^ Jamerson, Joshua (6 October 2016). "ICU Medical To Buy Pfizer Unit in $1 Billion Deal". The Wall Street Journal. Retrieved 28 April 2017.
- ^ "ICU Medical Completes the Acquisition of Hospira Infusion Systems from Pfizer". ICU Medical. Retrieved 28 April 2017.
- U.S. Food and Drug Administration. December 2021. Retrieved 2022-05-24.
- ^ Thatcher, Virginia S. (1953). "Chapter 7: Illegal or Legal?". History of Anesthesia with Emphasis on the Nurse Specialist. J.B. Lippincott. Archived from the original (PDF) on 2011-05-01.
- ^ Allen, Nick (27 September 2010). "US executions on hold due to lethal injection drug shortage". London: The Telegraph.
- ^ Welsh-Huggins, Andrew (27 September 2010). "Shortage of drug holds up some U.S. executions". NBC News. AP.
- ^ ISSN 0261-3077. Retrieved 2020-04-23.
- ^ "EU puts squeeze on drug supplies for U.S. executions". Reuters. 2011-12-20. Retrieved 2020-04-23.
- ^ a b Koppel, Nathan (January 22, 2011). "Drug Halt Hinders Executions in the U.S." The Wall Street Journal.
- New York Times.
- ^ "Hospira - Investor Relations - Press Release". corporate-ir.net.
- ^ "Sanofi-Aventis Settles Additional Eloxatin Suits". MarketWatch. 6 April 2010.
- ^ "Home - AARP Online Community". aarp.org.
- ^ "Hsp". CNN.
- ^ "NVD - Detail". nist.gov.
- ^ "Hospira LifeCare PCA Infusion System Vulnerabilities (Update B) - ICS-CERT". us-cert.gov.
- ^ "Billy (BK) Rios". xs-sniper.com.
- ^ "Symbiq Infusion System by Hospira: FDA Safety Communication - Cybersecurity Vulnerabilities". fda.gov.
- ^ "Researcher: Drug Pump the 'Least Secure IP Device I've Ever Seen' - The Security Ledger". The Security Ledger. 5 May 2015.
- ^ "Serious Security Flaws Found in Hospira LifeCare Drug Pumps - SecurityWeek.Com". securityweek.com. 6 May 2015.
- ^ Andrea Peterson (3 August 2015). "Connected medical devices: The Internet of things-that-could-kill-you". Washington Post.
External links
- Official website
- Historical business data for Hospira Inc.:
- SEC filings